Product Information
CETIRIZINE HCL 10 MG CHEW TAB is a generic product labeled by Sandoz Inc., priced at $2.1135 per EA under NDC 00781528464. Its NADAC has been published 590 times since Nov 28, 2013.
FDA first approved this application on Feb 14, 2008.
The High Outlier badge above means this manufacturer's average price in the Cetirizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781528464
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078692FDA Approved
2/14/2008
On Market Since
2/14/2008
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 10 MG CHEW TAB has been published 590 times since Nov 28, 2013, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1135 per EA |
|---|---|
| All-time high | $3.5438 (May 15, 2019) |
| All-time low | $0.4850 (Jul 23, 2014) |
| 52-week high | $2.2742 |
| 52-week low | $2.0247 |
| Median price | $2.0528 |
| Average price | $2.1773 |
| Largest weekly change | +372.6% (Nov 19, 2014) |
| Weeks tracked | 590 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 10 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 10 MG CHEW TAB, manufactured by Sandoz Inc., is $2.1135 per EA (NDC 00781528464), effective Sep 30, 2026.
How has the price of CETIRIZINE HCL 10 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 10 MG CHEW TAB has declined 7.1%. It has been tracked across 590 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 10 MG CHEW TAB?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 10 MG CHEW TAB has ranged from a low of $0.4850 (Jul 23, 2014) to a high of $3.5438 (May 15, 2019), with a median of $2.0528 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 10 MG CHEW TAB?
Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALL DAY ALLERGY 10 MG TABLET, is $0.0613 per EA — about 97% below CETIRIZINE HCL 10 MG CHEW TAB.
Who manufactures CETIRIZINE HCL 10 MG CHEW TAB?
CETIRIZINE HCL 10 MG CHEW TAB (NDC 00781528464) is labeled by Sandoz Inc., and CMS classifies it as a generic product.